NCT04430348View on ClinicalTrials.gov

PTX-35 in Patients With Advanced Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 4, 2020

Primary Completion Date

November 2, 2022

Study Completion Date

June 15, 2023

Conditions
Advanced Solid Tumor
Interventions
DRUG

PTX-35

Monoclonal antibody PTX-35

Trial Locations (3)

78229

Next Oncology, San Antonio

78705

NEXT Oncology Austin, Austin

97213

Providence Cancer Institute, Earle A. Chiles Research Institute, Portland

Sponsors
All Listed Sponsors
lead

Pelican Therapeutics, Inc.

INDUSTRY